{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T16:36:30Z","timestamp":1791736590712,"version":"4.3.4"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"DOI":"10.13039\/100002565","name":"Alzheimer's Drug Discovery Foundation","doi-asserted-by":"publisher","award":["20140901"],"award-info":[{"award-number":["20140901"]}],"id":[{"id":"10.13039\/100002565","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Alzheimer's Society (UK)","award":["20140901"],"award-info":[{"award-number":["20140901"]}]},{"name":"MRC","award":["MR\/N013638\/1"],"award-info":[{"award-number":["MR\/N013638\/1"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Trials"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s13063-017-1973-9","type":"journal-article","created":{"date-parts":[[2017,5,22]],"date-time":"2017-05-22T09:25:34Z","timestamp":1495445134000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Perfusion by Arterial Spin labelling following Single dose Tadalafil In Small vessel disease (PASTIS): study protocol for a randomised controlled trial"],"prefix":"10.1186","volume":"18","author":[{"given":"Mathilde M. H.","family":"Pauls","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natasha","family":"Clarke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Trippier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shai","family":"Betteridge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franklyn A.","family":"Howe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Usman","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Kruuse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeremy B.","family":"Madigan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barry","family":"Moynihan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony C.","family":"Pereira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debbie","family":"Rolfe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Egill","family":"Rostrup","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline E.","family":"Haig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas R.","family":"Barrick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeremy D.","family":"Isaacs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atticus H.","family":"Hainsworth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,5,22]]},"reference":[{"key":"1973_CR1","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1016\/S0140-6736(15)00463-8","volume":"386","author":"JT O\u2019Brien","year":"2015","unstructured":"O\u2019Brien JT, Thomas A. Vascular dementia. Lancet. 2015;386:1698\u2013706.","journal-title":"Lancet"},{"key":"1973_CR2","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/S1474-4422(10)70104-6","volume":"9","author":"L Pantoni","year":"2010","unstructured":"Pantoni L. Cerebral small vessel disease: from pathogenesis and clinical characteristics to therapeutic challenges. Lancet Neurol. 2010;9:689\u2013701.","journal-title":"Lancet Neurol"},{"key":"1973_CR3","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1136\/jnnp.63.6.749","volume":"63","author":"MM Esiri","year":"1997","unstructured":"Esiri MM, Wilcock GK, Morris JH. Neuropathological assessment of the lesions of significance in vascular dementia. J Neurol Neurosurg Psychiatry. 1997;63:749\u201353.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1973_CR4","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1177\/0271678X15621574","volume":"37","author":"ET Ighodaro","year":"2017","unstructured":"Ighodaro ET, Abner EL, Fardo DW, Lin AL, Katsumata Y, Schmitt FA, et al. Risk factors and global cognitive status related to brain arteriolosclerosis in elderly individuals. J Cereb Blood Flow Metab. 2017;37:201\u201316.","journal-title":"J Cereb Blood Flow Metab"},{"key":"1973_CR5","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1136\/jnnp.69.1.48","volume":"69","author":"HS Markus","year":"2000","unstructured":"Markus HS, Lythgoe DJ, Ostegaard L, O\u2019Sullivan M, Williams SC. Reduced cerebral blood flow in white matter in ischaemic leukoaraiosis demonstrated using quantitative exogenous contrast based perfusion MRI. J Neurol Neurosurg Psychiatry. 2000;69:48\u201353.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1973_CR6","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1212\/WNL.59.3.321","volume":"59","author":"M O\u2019Sullivan","year":"2002","unstructured":"O\u2019Sullivan M, Lythgoe DJ, Pereira AC, Summers PE, Jarosz JM, Williams SC, et al. Patterns of cerebral blood flow reduction in patients with ischemic leukoaraiosis. Neurology. 2002;59:321\u20136.","journal-title":"Neurology"},{"key":"1973_CR7","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.jalz.2009.04.1233","volume":"5","author":"N Schuff","year":"2009","unstructured":"Schuff N, Matsumoto S, Kmiecik J, Studholme C, Du A, Ezekiel F, et al. Cerebral blood flow in ischemic vascular dementia and Alzheimer\u2019s disease, measured by arterial spin-labeling magnetic resonance imaging. Alzheimers Dement. 2009;5:454\u201362.","journal-title":"Alzheimers Dement"},{"key":"1973_CR8","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1161\/01.STR.23.11.1673","volume":"23","author":"H Yao","year":"1992","unstructured":"Yao H, Sadoshima S, Ibayashi S, Kuwabara Y, Ichiya Y, Fujishima M. Leukoaraiosis and dementia in hypertensive patients. Stroke. 1992;23:1673\u20137.","journal-title":"Stroke"},{"key":"1973_CR9","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1038\/jcbfm.2015.92","volume":"35","author":"M Bernbaum","year":"2015","unstructured":"Bernbaum M, Menon BK, Fick G, Smith EE, Goyal M, Frayne R, et al. Reduced blood flow in normal white matter predicts development of leukoaraiosis. J Cereb Blood Flow Metab. 2015;35:1610\u20135.","journal-title":"J Cereb Blood Flow Metab"},{"key":"1973_CR10","doi-asserted-by":"publisher","unstructured":"Arba F, Mair G, Carpenter T, Sakka E, Sandercock PA, Lindley RI, et al. Cerebral white matter hypoperfusion increases with small-vessel disease burden: data from the Third International Stroke Trial. J Stroke Cerebrovasc Dis. doi: \n10.1016\/j.jstrokecerebrovasdis.2017.03.002\n\n.","DOI":"10.1016\/j.jstrokecerebrovasdis.2017.03.002"},{"key":"1973_CR11","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1146\/annurev.biochem.76.060305.150444","volume":"76","author":"M Conti","year":"2007","unstructured":"Conti M, Beavo J. Biochemistry and physiology of cyclic nucleotide phosphodiesterases: essential components in cyclic nucleotide signaling. Annu Rev Biochem. 2007;76:481\u2013511.","journal-title":"Annu Rev Biochem"},{"key":"1973_CR12","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1021\/cn3000907","volume":"3","author":"A Garcia-Osta","year":"2012","unstructured":"Garcia-Osta A, Cuadrado-Tejedor M, Garcia-Barroso C, Oyarzabal J, Franco R. Phosphodiesterases as therapeutic targets for Alzheimer\u2019s disease. ACS Chem Neurosci. 2012;3:832\u201344.","journal-title":"ACS Chem Neurosci"},{"key":"1973_CR13","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1038\/nrd4228","volume":"13","author":"DH Maurice","year":"2014","unstructured":"Maurice DH, Ke H, Ahmad F, Wang Y, Chung J, Manganiello VC. Advances in targeting cyclic nucleotide phosphodiesterases. Nat Rev Drug Discov. 2014;13:290\u2013314.","journal-title":"Nat Rev Drug Discov"},{"key":"1973_CR14","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.neuropharm.2010.05.004","volume":"59","author":"V Lakics","year":"2010","unstructured":"Lakics V, Karran EH, Boess FG. Quantitative comparison of phosphodiesterase mRNA distribution in human brain and peripheral tissues. Neuropharmacology. 2010;59:367\u201374.","journal-title":"Neuropharmacology"},{"key":"1973_CR15","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.ejphar.2005.07.017","volume":"521","author":"C Kruuse","year":"2005","unstructured":"Kruuse C, Khurana TS, Rybalkin SD, Birk S, Engel U, Edvinsson L, et al. Phosphodiesterase 5 and effects of sildenafil on cerebral arteries of man and guinea pig. Eur J Pharmacol. 2005;521:105\u201314.","journal-title":"Eur J Pharmacol"},{"key":"1973_CR16","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1111\/j.1365-2125.2005.02553.x","volume":"61","author":"ST Forgue","year":"2006","unstructured":"Forgue ST, Patterson BE, Bedding AW, Payne CD, Phillips DL, Wrishko RE, et al. Tadalafil pharmacokinetics in healthy subjects. Br J Clin Pharmacol. 2006;61:280\u20138.","journal-title":"Br J Clin Pharmacol"},{"key":"1973_CR17","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1111\/j.1365-2125.2006.02726.x","volume":"63","author":"ST Forgue","year":"2007","unstructured":"Forgue ST, Phillips DL, Bedding AW, Payne CD, Jewell H, Patterson BE, et al. Effects of gender, age, diabetes mellitus and renal and hepatic impairment on tadalafil pharmacokinetics. Br J Clin Pharmacol. 2007;63:24\u201335.","journal-title":"Br J Clin Pharmacol"},{"key":"1973_CR18","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1016\/j.amjcard.2005.12.073","volume":"97","author":"RA Kloner","year":"2006","unstructured":"Kloner RA, Jackson G, Hutter AM, Mittleman MA, Chan M, Warner MR, et al. Cardiovascular safety update of tadalafil: retrospective analysis of data from placebo-controlled and open-label clinical trials of tadalafil with as needed, three times-per-week or once-a-day dosing. Am J Cardiol. 2006;97:1778\u201384.","journal-title":"Am J Cardiol"},{"key":"1973_CR19","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.neuropharm.2012.06.052","volume":"64","author":"C Garcia-Barroso","year":"2013","unstructured":"Garcia-Barroso C, Ricobaraza A, Pascual-Lucas M, Unceta N, Rico AJ, Goicolea MA, et al. Tadalafil crosses the blood-brain barrier and reverses cognitive dysfunction in a mouse model of AD. Neuropharmacology. 2013;64:114\u201323.","journal-title":"Neuropharmacology"},{"key":"1973_CR20","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1002\/mrm.25197","volume":"73","author":"DC Alsop","year":"2015","unstructured":"Alsop DC, Detre JA, Golay X, Gunther M, Hendrikse J, Hernandez-Garcia L, et al. Recommended implementation of arterial spin-labeled perfusion MRI for clinical applications: a consensus of the ISMRM perfusion study group and the European consortium for ASL in dementia. Magn Reson Med. 2015;73:102\u201316.","journal-title":"Magn Reson Med"},{"key":"1973_CR21","doi-asserted-by":"crossref","first-page":"5654","DOI":"10.1073\/pnas.1222560110","volume":"110","author":"M D\u2019haeseleer","year":"2013","unstructured":"D\u2019haeseleer M, Beelen R, Fierens Y, Cambron M, Vanbinst AM, Verborgh C, et al. Cerebral hypoperfusion in multiple sclerosis is reversible and mediated by endothelin-1. Proc Natl Acad Sci U S A. 2013;110:5654\u20138.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1973_CR22","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1192\/bjp.bp.111.092387","volume":"200","author":"SJ Colloby","year":"2012","unstructured":"Colloby SJ, Firbank MJ, He J, Thomas AJ, Vasudev A, Parry SW, et al. Regional cerebral blood flow in late-life depression: arterial spin labelling magnetic resonance study. Br J Psychiatry. 2012;200:150\u20135.","journal-title":"Br J Psychiatry"}],"container-title":["Trials"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-017-1973-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,5,22]],"date-time":"2017-05-22T09:25:40Z","timestamp":1495445140000},"score":1,"resource":{"primary":{"URL":"http:\/\/trialsjournal.biomedcentral.com\/articles\/10.1186\/s13063-017-1973-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5,22]]},"references-count":22,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["1973"],"URL":"https:\/\/doi.org\/10.1186\/s13063-017-1973-9","relation":{},"ISSN":["1745-6215"],"issn-type":[{"value":"1745-6215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,5,22]]},"article-number":"229"}}